Taiwan Liposome Company, Ltd.;TLC Biopharmaceuticals, Inc.
发明人:
KAN, Pei,TSENG, Yun-Long,OU, Han, Chun
申请号：
DK14764361
公开号：
DK2968146T3
申请日:
2014.03.15
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.
